A detailed history of Acropolis Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 3,878 shares of ABBV stock, worth $781,417. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,878
Previous 5,563 30.29%
Holding current value
$781,417
Previous $1.01 Million 34.35%
% of portfolio
0.04%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $260,821 - $304,580
-1,685 Reduced 30.29%
3,878 $665,000
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $319 - $364
-2 Reduced 0.04%
5,563 $1.01 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $10,182 - $11,467
74 Added 1.35%
5,565 $862,000
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $290,157 - $335,899
2,172 Added 65.44%
5,491 $818,000
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $134,232 - $167,043
1,013 Added 43.93%
3,319 $447,000
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $1,446 - $1,665
-10 Reduced 0.43%
2,306 $367,000
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $4,979 - $5,971
-36 Reduced 1.53%
2,316 $0
Q3 2022

Oct 12, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 4.08%
2,352 $316,000
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $4,541 - $5,773
33 Added 1.36%
2,452 $375,000
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $10,205 - $12,913
95 Added 4.09%
2,419 $327,000
Q1 2021

Apr 12, 2021

BUY
$102.3 - $112.62 $18,925 - $20,834
185 Added 8.65%
2,324 $251,000
Q4 2020

Jan 13, 2021

SELL
$80.49 - $108.67 $16,097 - $21,734
-200 Reduced 8.55%
2,139 $229,000
Q3 2020

Oct 09, 2020

BUY
$85.91 - $100.83 $31,443 - $36,903
366 Added 18.55%
2,339 $205,000
Q2 2020

Jul 15, 2020

SELL
$73.37 - $98.18 $1,760 - $2,356
-24 Reduced 1.2%
1,973 $194,000
Q1 2020

Apr 10, 2020

SELL
$64.5 - $97.79 $11,610 - $17,602
-180 Reduced 8.27%
1,997 $152,000
Q4 2019

Jan 14, 2020

BUY
$72.13 - $90.25 $5,481 - $6,859
76 Added 3.62%
2,177 $186,000
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $314 - $378
5 Added 0.24%
2,101 $159,000
Q2 2019

Jul 11, 2019

SELL
$65.7 - $83.98 $12,745 - $16,292
-194 Reduced 8.47%
2,096 $152,000
Q1 2019

Apr 09, 2019

BUY
$77.14 - $90.79 $308 - $363
4 Added 0.17%
2,290 $185,000
Q4 2018

Jan 10, 2019

BUY
$77.85 - $96.01 $155 - $192
2 Added 0.09%
2,286 $211,000
Q3 2018

Oct 03, 2018

SELL
$88.91 - $98.84 $4,623 - $5,139
-52 Reduced 2.23%
2,284 $216,000
Q2 2018

Jul 12, 2018

BUY
$89.78 - $106.23 $27,203 - $32,187
303 Added 14.9%
2,336 $216,000
Q1 2018

Apr 04, 2018

BUY
$92.01 - $123.21 $16,377 - $21,931
178 Added 9.6%
2,033 $192,000
Q4 2017

Jan 11, 2018

BUY
$89.56 - $98.21 $18,897 - $20,722
211 Added 12.83%
1,855 $179,000
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $37,858 - $48,357
542 Added 49.18%
1,644 $146,000
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $76,974 - $98,320
1,102
1,102 $146,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.